As a leading dermatology company, Evocutis provides a comprehensive range of contract research services to support skin science R&D. Whether it’s conducting innovative research, selecting the most effective formulation or supporting a new marketing claim Evocutis can help speed up development programmes. The company has three main areas of specialism:
- Skin microbiology
- Living Skin Equivalents
- Clinical evaluations
|
As at 31 Dec 2012 |
IP Group holding |
IP Venture Fund* holding |
16.7% |
7.9% |
|
*IP Group has a 10%
economic interest in IP
Venture Fund |
Holdings represent undiluted beneficial equity interest excluding debt